Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health Immunization topic
No spam. Unsubscribe anytime.
Finance Committee advances Universal Immunization Program after hours of pro‑/con testimony
Summary
Senate Bill 14‑34 SD1 HD1 — creating a Universal Immunization Purchase (UIP) program and special fund — passed the House Finance committee after dozens of written and oral testimonies both supporting and opposing the proposal. The measure drew sustained public comment for and against financing, mandate concerns and program oversight.
The House Committee on Finance voted to advance Senate Bill 14‑34 SD1 HD1, a bill that would create a universal immunization purchase program to expand and streamline vaccine access across age groups and to create a dedicated special fund to support the program.
Supporters — including the Department of Health, the Hawai‘i chapter of the American Academy of Pediatrics and federally qualified health centers — testified that a centralized purchase program would reduce the cost burden on small providers, prevent supply shortages during outbreaks and remove access barriers for populations on neighbor islands and in under‑served communities. Ron Balaharia, Immunization Branch Chief for the Department of Health, said the department “strongly supports SB1434” and described a one‑time startup request to build the administrative infrastructure; he told the committee the program would become self‑sustaining through plan assessments after the launch year.
Pediatricians and public‑health advocates said vaccine‑preventable disease outbreaks would carry high medical and fiscal costs and that a state program could prevent hospitalizations and save money over time. The American Academy of Pediatrics’ representative emphasized the comparative cost of a vaccine versus the long‑term care and hospital costs for severe disease.
Opponents ranged from individual citizens to organized community groups who warned the proposal creates a new assessment on insurers and could increase premiums, raises questions about a new special fund’s oversight, and — for some speakers — represented an overreach into parents’ vaccine decisions. Multiple public commenters also urged increased investment in overall community health and education rather than a centralized purchasing program.
Committee members discussed fiscal oversight, the fund structure and whether the UIP would duplicate existing federal programs such as Vaccines for Children (VFC). The Department of Health said VFC would remain part of the financing mix; the UIP is intended to supplement access and cover gaps in adult and other vaccine access.
Action: The committee recorded a recommendation to pass the bill unamended, noting one recorded no vote in committee. The committee’s report states the bill will create a special fund financed by assessed entities and one‑time startup funds, with the department responsible for administration. Several legislators asked for clearer spending projections and limits before final appropriation, and the committee retained oversight language for future reports.
Ending: The bill moves forward to the next stage with mixed public commentary and a requirement that the administration provide the requested startup details and projected administrative costs in follow‑up testimony.
